• Guest Post   |
  • Submit App Review   |
  • Submit PR   |
  • Advertise   |
  • Contact Us
  • Login
No Result
View All Result
Advertisement
Mobile App Development | Design | Marketing Magazine: Appedus
Subscribe
  • Home
  • App Development
  • App Marketing
    • All
    • App Onboarding
    • App Store Optimisation
    • App User Engagement
    • Push Notifications
    How to market a mobile app

    6 ways to market a mobile app

    Latest mobile app trends

    6 Latest mobile app trends

    5-Ways-To-Promote-Your-Mobile-App-In-A-Smarter-Way-scaled-appedus

    5 Ways To Promote Your Mobile App In A Smarter Way

    Get-Your-App-The-Most-Downloads-On-The-Apple-App-Store-Appedus

    How To Get Your App The Most Downloads On The Apple App Store

    Trending Tags

      • App Store Optimisation
      • App User Engagement
      • App Push Notifications
      • App Onboarding
      • App Analytics
    • App Design
    • App Reviews
      • All
      • Books & Reference
      • Business
      • Dating
      • Education
      • Finance
      • Fitness
      • Food & Drink
      • Health
      • iOS apps
      • Lifestyle
      • Medical
      • Photography
      • Productivity
      • Shopping
      • Social
      • Travel
      • Utilities
      • Video Editing
      6-iOS-Productivity-Apps-I-Cant-Live-Without-appedus

      6 Best iOS Productivity Apps You Can’t Live Without

      7-Reasons-Why-Every-Business-Should-Be-Mobile-Friendly-appedus

      7 Reasons Why Every Business Should Be Mobile-Friendly

      The-top-ten-mobile-apps-all-travellers-should-use-appedus

      The top ten mobile apps all travelers should use

      5-Ways-To-Promote-Your-Mobile-App-In-A-Smarter-Way-scaled-appedus

      5 Ways To Promote Your Mobile App In A Smarter Way

      What-To-Do-If-Your-Cell-Phone-Is-Lost-or-Stolen-appedus

      What To Do If Your Cell Phone Is Lost or Stolen

      Free-Android-Meme-Maker-Appedus

      5 Best Free Android Meme Maker

      Zerodha Kite App Review

      Zerodha Kite App Review: A great way to start investing

      Crello App Review

      Crello App Review 2022 | An Attractive Editing Tool

      8fit App Review

      8fit App Review 2022 | Workouts and Meal Planner

      Trending Tags

      • Travel
      • fitness
      • Video Editing app
      • Utilities
      • Lifestyle
      • Medical
      • Photography
      • Productivity
      • Shopping
      • Social
      • Travel
    • App Events
    • Exclusive
    • Home
    • App Development
    • App Marketing
      • All
      • App Onboarding
      • App Store Optimisation
      • App User Engagement
      • Push Notifications
      How to market a mobile app

      6 ways to market a mobile app

      Latest mobile app trends

      6 Latest mobile app trends

      5-Ways-To-Promote-Your-Mobile-App-In-A-Smarter-Way-scaled-appedus

      5 Ways To Promote Your Mobile App In A Smarter Way

      Get-Your-App-The-Most-Downloads-On-The-Apple-App-Store-Appedus

      How To Get Your App The Most Downloads On The Apple App Store

      Trending Tags

        • App Store Optimisation
        • App User Engagement
        • App Push Notifications
        • App Onboarding
        • App Analytics
      • App Design
      • App Reviews
        • All
        • Books & Reference
        • Business
        • Dating
        • Education
        • Finance
        • Fitness
        • Food & Drink
        • Health
        • iOS apps
        • Lifestyle
        • Medical
        • Photography
        • Productivity
        • Shopping
        • Social
        • Travel
        • Utilities
        • Video Editing
        6-iOS-Productivity-Apps-I-Cant-Live-Without-appedus

        6 Best iOS Productivity Apps You Can’t Live Without

        7-Reasons-Why-Every-Business-Should-Be-Mobile-Friendly-appedus

        7 Reasons Why Every Business Should Be Mobile-Friendly

        The-top-ten-mobile-apps-all-travellers-should-use-appedus

        The top ten mobile apps all travelers should use

        5-Ways-To-Promote-Your-Mobile-App-In-A-Smarter-Way-scaled-appedus

        5 Ways To Promote Your Mobile App In A Smarter Way

        What-To-Do-If-Your-Cell-Phone-Is-Lost-or-Stolen-appedus

        What To Do If Your Cell Phone Is Lost or Stolen

        Free-Android-Meme-Maker-Appedus

        5 Best Free Android Meme Maker

        Zerodha Kite App Review

        Zerodha Kite App Review: A great way to start investing

        Crello App Review

        Crello App Review 2022 | An Attractive Editing Tool

        8fit App Review

        8fit App Review 2022 | Workouts and Meal Planner

        Trending Tags

        • Travel
        • fitness
        • Video Editing app
        • Utilities
        • Lifestyle
        • Medical
        • Photography
        • Productivity
        • Shopping
        • Social
        • Travel
      • App Events
      • Exclusive
      No Result
      View All Result
      Mobile App Development | Design | Marketing Magazine: Appedus
      No Result
      View All Result
      Home Featured

      Immunai raises $215M in a Series B funding round

      Immunai, a biotech business, will use the funds to develop and improve a cell treatment for neuroblastoma in partnership with Baylor College of Medicine.

      by Editorial Team
      October 28, 2021
      in Featured, Funding, News-Curated, Tech
      Reading Time: 4 mins read
      0
      Immunai

      Source: Google Images

      Share on FacebookShare on Twitter

      Main Highlights:

      • On Wednesday, Immunai announced a $215 million Series B capital round.
      • According to Noam Solomon, Immunai’s CEO and co-founder, the unexpected surge in funding is due to AMICA’s many forms of insights.
      • This technology is now being used to develop and improve a cell treatment for neuroblastoma in partnership with Baylor College of Medicine.
      • Immunai collects a lot of data about its users. Immunai has worked with over 30 businesses, and universities reprint Genomics for an unknown price in March. The company was working on large-scale single-cell sequencing.

      Immunai, a biotech company, has had a great deal of success raising capital. By the end of February 2021, the company that set out to create an atlas of the human Immunai system had garnered approximately $80 million in funding. On Wednesday, the company announced a new, far larger round of funding: a $215 million investment in series B financing.

      A vast amount of clinical immunology data has taken Immunai years to collect and arrange, and this has taken years longer than anticipated. Scientists combine genetic data with other sources of information to better understand how the Immunai system functions. Examples of such sources of information include epigenetic changes and proteomics. Machine learning makes it possible to uncover which targets would be helpful for drugmakers, which drugs might cause hazardous reactions, and eventually predict how a patient may respond to a given treatment.

      Immunai’s aim:

      According to Immunai, the Annotated Multi-omic Immunai Cell Atlas, or AMICA, is the largest of its kind in the world. Up to this point, the company has attracted $295 million in venture capital, with Koch Disruptive Technologies serving as the lead investor and participation from additional investors such as Talos VC, 8VC, Alexandria Venture Investments, Piedmont, and ICON.

      Currently, cell therapy for neuroblastoma is being developed and enhanced in collaboration with the Baylor College of Medicine, and this platform is being used in this process. According to Solomonccording to Solomon, a report demonstrating that the company can identify specific gene targets that predict whether or not a patient would respond to particular treatments is also in the works. Solomon expresses himself.

      Immunai founders

      According to Noam Solomon, the company can deliver causative data rather than just correlational data for the time being. He goes on to say that they were demonstrating substantial correlation evidence about a year ago, indicating that some of the insights they’d gathered may be used to explain connections between genes and cells.

      As a result of scientific advancements, there are more causal inference outcomes available now than ever before. Through their functional genomics platform, they will demonstrate that their efforts are producing specific products.

      While Immunai is one business aiming to use cell-level data, it is by no means the only one in this field of endeavor. In the same market, there are many enterprises of varied sizes competing against one another. Immunai is distinguished in Solomon’s view by two characteristics.

      To begin, Immunai is accumulating a massive amount of information about its users. Immunai has collaborated with more than 30 companies and academic organizations. However, this year’s purchases have increased the types of biological data that the company may collect and manage due to two essential investments made by the company.

      Immunai purchased Immunai acquired Dropprint Genomics in March for an undisclosed sum. The company was engaged in the development of technologies for large-scale single-cell sequencing. According to Solomon, dropping has made “interesting progress on autoimmunity,” and he credits the company for this. Immunai purchased Nebion, a 13-year-old Swiss company specializing in creating gene expression data sets, this summer. As well as internal collaborations, according to Solomon, they have 70 external relationships with hospitals and universities.

      According to Solomon, both acquisitions “substantially hastened the expansion of the database.” To acquire complementary technology, however, the M&A approach remains unchanged… As time goes on, Immunai’s data collecting strategy will be heavily influenced by the formation of new collaborations.

      Immunai’s distinctiveness, according to Solomon, stems from the company’s approach to handling sensitive data. This is because Solomon is equally concerned with developing the infrastructure to manage the data set as he is with the data itself, rather than with labeling Immunai as an engineering-first company, as others have done.

      According to him, around half of the company’s 120 employees come from purely technical or engineering backgrounds. Following the completion of this financing, the company wants to hire additional employees and continue to expand its immunological data library (as well as the supporting back-end infrastructure). From a business sense, it also means that the organization is less reliant on upfront payments from prospective partners than it was previously. As a result of the extra finance, the company’s emphasis has moved slightly.

      mm

      Editorial Team

      We at Appedus are a group of digital nomads aggregating, writing, and publishing the best of the tech news in the mobile app ecosystem. Our constant endeavor is to get the most actionable news for you to use.

      Next Post
      BlueSemi

      BlueSemi, a healthtech business, raises $69M in preparation for an initial public offering

      Weekly Newsletter

      Top Apps This Week

      Google Now Just Made It Even Easier To Track Your Favorite TV Shows And Movies
      Featured

      Google Now Just Made It Even Easier To Track Your Favorite TV Shows And Movies

      by Editorial
      January 7, 2023

      Today’s announcement by Google of a new feature for their...

      Read more
      6-iOS-Productivity-Apps-I-Cant-Live-Without-appedus

      6 Best iOS Productivity Apps You Can’t Live Without

      December 31, 2022
      7-Reasons-Why-Every-Business-Should-Be-Mobile-Friendly-appedus

      7 Reasons Why Every Business Should Be Mobile-Friendly

      December 26, 2022
      Load More

      About Us

      Mobile App Development | Design | Marketing Magazine: Appedus

      Appedus is a mobile app ecosystem focused news publishing platform which covers various topics like app design, app development, app marketing and other relevant news, views or opinions. We also publish industry insights, e-books, developer interviews and e-magazines. You can get in touch with us on hola@appedus.com or you can snail mail us at

      Medianiti Ltd. Brooklands Business Park, Wellington Way, Weybridge KT13 0TT, United Kingdom

      Latest Articles & News

      How to market a mobile app

      6 ways to market a mobile app

      January 18, 2023
      Best practices for mobile app design

      Best practices for mobile app design

      January 17, 2023

      Important Links

      • Guest Post
      • Submit App Review
      • Submit PR
      • Mobile App Marketing
      • Mobile App Reviews | Top Android & iOS app reviews
      • Top Apps
      • Curated News
      • Advertise
      • Contact Us

      Subscribe

      • Advertise
      • App Events
      • Appedus
      • Contact Us
      • Exclusive at Appedus
      • Our Authors, Contributors & Writers
      • Privacy Policy
      • Submit App for Review
      • Submit Free Press Release
      • Thank You
      • Tip-Off
      • Write For Us | Mobile App Development Guest Post
      • Write For Us | Mobile App Development Guest Post Paid

      © 2022 Appedus - Appedus All Right Reserved

      No Result
      View All Result
      • Advertise
      • App Events
      • Appedus
      • Contact Us
      • Exclusive at Appedus
      • Our Authors, Contributors & Writers
      • Privacy Policy
      • Submit App for Review
      • Submit Free Press Release
      • Thank You
      • Tip-Off
      • Write For Us | Mobile App Development Guest Post
      • Write For Us | Mobile App Development Guest Post Paid

      © 2022 Appedus - Appedus All Right Reserved

      Welcome Back!

      OR

      Login to your account below

      Forgotten Password?

      Retrieve your password

      Please enter your username or email address to reset your password.

      Log In
      This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
      Go to mobile version